Latest John M. Maris Stories
An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease.
Pediatric cancer researchers have identified variations in a gene as important contributors to neuroblastoma, the most common solid cancer of early childhood.
Using immunotherapyâ€”biologic agents that stimulate the bodyâ€™s immune systemâ€”pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma.
-- New Standard of Care in High-Risk Neuroblastoma Seen in Immunotherapy Results-- PHILADELPHIA, Sept.
CHOP oncology chief working to translate his lab's genetic findings into treatments.
--CHOP Oncology Chief Working to Translate His Lab's Genetic Findings into Treatments-- PHILADELPHIA, June 14 /PRNewswire-USNewswire/ -- Pediatric oncologist John M. Maris, M.D., describes the current state of the science in combating neuroblastoma, the most common solid cancer of early childhood.
--Whole-Genome Searches Are Revealing Secrets of a Childhood Cancer-- PHILADELPHIA, June 22 /PRNewswire-USNewswire/ -- Two new studies from The Children's Hospital of Philadelphia advance the search for genetic events that result in neuroblastoma, a puzzling, often-deadly type of childhood cancer. Originating in the peripheral nervous system, neuroblastoma is the most common solid cancer of early childhood and causes 15 percent of all childhood cancer deaths. "Only two years ago we had...
- In a First, Immunotherapy Works Against Neuroblastoma - PHILADELPHIA, June 22 /PRNewswire-USNewswire/ -- A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system. John M.
Two new studies from The Children's Hospital of Philadelphia advance the search for genetic events that result in neuroblastoma, a puzzling, often deadly type of childhood cancer.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.